Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
City of Hope Medical Center
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Roswell Park Cancer Institute
City of Hope Medical Center
Fred Hutchinson Cancer Center
Mayo Clinic
Fred Hutchinson Cancer Center
Mayo Clinic
Mayo Clinic